Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > UQ's needle free vaccine delivery research recognised

Professor Kendall
Professor Kendall

Abstract:
University of Queensland researcher Professor Mark Kendall has been awarded the 2008 Amgen Medical Research Award for his excellence in translational medical research studies.

UQ's needle free vaccine delivery research recognised

Australia | Posted on June 6th, 2008

This national award is made annually by the Australian Society for Medical Research as part of Medical Research Week.

Professor Kendall leads a research team at the Australian Institute for Bioengineering and Nanotechnology (AIBN) developing needle-free delivery of vaccines targeting the skin.

"I am delighted and honoured with the award, it offers me great encouragement at this stage of my career," Professor Kendall said.

"Our research is focused on practical needle-free devices accurately targeting key skin cells, with the goal of clinical application of better vaccines in both the developed and developing world.

"To help optimise our delivery devices, we are performing fundamental research into the mechanical and biological properties of the skin, together with vaccine delivery studies in key disease areas."

Professor Kendall joined UQ in 2006 as a joint appointment by AIBN, the Diamantina Institute for Cancer, Immunology and Metabolic Medicine and the Faculty of Health Sciences. Prior to this he was the Associate Director of the PowderJect Centre for Gene and Drug Delivery at Oxford University, UK.

In congratulating Professor Kendall, AIBN Director Professor Peter Gray said his work typified the research excellence to be found at the AIBN.

"Mark's work is multidisciplinary in nature, combining vaccine science, bioengineering together with biomaterials and microfabrication, and it typifies AIBN's dynamic research environment and industry focus," Professor Gray said.

Director of the Diamantina Institute Professor Ian Frazer said that Professor Kendall's work was an important collaboration between the Institutes.

"This collaborative project offers great hope in reducing the estimated 14 million deaths caused each year by infectious diseases and, due to its robustness and efficiency, could be of particular benefit in developing countries," Professor Frazer said.

The AIBN is a multi-disciplinary research institute based at UQ, which brings together the skills of world-class researchers in the areas of bioengineering and nanotechnology to produce positive health and environmental outcomes such as biomedical delivery; bio-devices; tissue regeneration; and cell therapies.

####

For more information, please click here

Contacts:
Professor Mark Kendall
0431 162 391
or
Russell Griggs
07 3346 3989

Copyright © University of Queensland

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014

UCF Nanotech Spinout Developing Revolutionary Battery Technology: Power the Next Generation of Electronics with Carbon July 23rd, 2014

Deadline Announced for Registration in 7th Int'l Nanotechnology Festival in Iran July 23rd, 2014

A Crystal Wedding in the Nanocosmos July 23rd, 2014

Nanomedicine

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

SentiMag® Now Available in Australia and New Zealand July 21st, 2014

More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014

Announcements

Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014

UCF Nanotech Spinout Developing Revolutionary Battery Technology: Power the Next Generation of Electronics with Carbon July 23rd, 2014

Deadline Announced for Registration in 7th Int'l Nanotechnology Festival in Iran July 23rd, 2014

A Crystal Wedding in the Nanocosmos July 23rd, 2014

Grants/Awards/Scholarships/Gifts/Contests/Honors/Records

Hysitron is Awarded TWO R&D 100 Awards for Highly Innovative Technology Developments in the Areas of Extreme Environments and Biological Mechanical Property Testing July 23rd, 2014

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

EPFL Research on the use of AFM based nanoscale IR spectroscopy for the study of single amyloid molecules wins poster competition at Swiss Physics Society meeting July 22nd, 2014

Carbyne morphs when stretched: Rice University calculations show carbon-atom chain would go metal to semiconductor July 21st, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE